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a  b  s  t  r  a  c  t
Nailfold capillaroscopy is a simple, low-cost method, that is extremely important in the
evaluation of patients with Raynaud’s phenomenon and of patients with systemic sclerosis
(SSc)  spectrum diseases. Besides its importance for the early diagnosis of SSc, nailfold capil-
laroscopy is a useful tool to identify scleroderma patients with high risk for development of
vascular and visceral complications and death. The inclusion of capillaroscopy in the new
classiﬁcation criteria for SSc of the American College of Rheumatology (ACR) and European
League Against Rheumatism (Eular) gives a new impetus to the use and dissemination of
the  method. In this paper, we present a didactic, non-systematic review on the subject, with
emphasis on advances recently described.
© 2014 Elsevier Editora Ltda. All rights reserved.





r  e  s  u  m  o
A capilaroscopia periungueal é um método simples, de baixo custo, e de extrema relevância
na  avaliac¸ão de pacientes com fenômeno de Raynaud ou portadores de doenc¸as do espectro
da  esclerose sistêmica (ES). Além de sua importância para o diagnóstico precoce da ES, con-
stitui  instrumento útil na identiﬁcac¸ão de pacientes esclerodérmicos com risco elevado para
o  desenvolvimento de complicac¸ões vasculares, viscerais e de óbito. A inclusão da capilaro-
scopia nos novos critérios para classiﬁcac¸ão da ES do Colégio Americano de Reumatologia(ACR) e da Liga Europeia Contra o Reumatismo (Eular) dá novo impulso para a utilizac¸ão e
odo.disseminac¸ão do métnão sistemática, sobre o t
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2255-5021/© 2014 Elsevier Editora Ltda. All rights reserved. No presente artigo, pretendemos apresentar uma  revisão didática,ema, com ênfase nos avanc¸os recentemente descritos.
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reomicroscope, it is possible an overall assessment of
nailfold beds, to register qualitative and quantitative
parameters.5,19 This remains the main method still used
Table 1 – Main indications for capillaroscopy.
(a) Evaluation of patients with Raynaud’s phenomenon
(b) Monitoring the transition from primary to secondary RP
(c) Early diagnosis of SSc
(d) Differential diagnosis of SSc-related conditions, such as
localized SSc and eosinophilic fasciitis, which usually have a
normal capillaroscopic pattern
(e) Detection of severe microangiopathy and prognostic evaluationr e v b r a s r e u m a t o l
ntroduction  and  brief  history
ascular changes characterized by functional and structural
bnormalities of the microcirculation play a central role in
he pathogenesis of systemic sclerosis (SSc) and may also be
resent in dermatomyositis (DM) and in the SSc spectrum
iseases.1 Nailfold capillaroscopy (NFC) is a non-invasive,
nexpensive and reproducible imaging method allowing the
valuation of structural changes in the peripheral microcircu-
ation. It is mainly used in the differentiation of primary and
econdary Raynaud’s phenomenon (RP) and in the diagnosis
f SSc.2,3
The history of capillaroscopy started 400 years ago, when JC
olhaus described the possibility of visualization of capillary
oops of the nailfold region through a rudimentary system of
ptical magniﬁcation.3 However, only in the second half of the
0th Century NFC begins to be used more  systematically in the
valuation of RP, in particular, thanks to the studies of Hilde-
ard Maricq and Edward Carwile LeRoy, who described in 1973
peciﬁc capillaroscopic patterns of SSc and related diseases.4
n Brazil, the method was introduced and standardized in
he 80s by Luís Eduardo Coelho Andrade.5 In recent years,
esearchers have turned their attention to the NFC because
f new evidence of the importance of the method for early
iagnosis of SSc and its prognostic value. In addition, NFC has
ecently been incorporated into the new classiﬁcation crite-
ia of the ACR/EULAR 2013 for SSc, conﬁrming the importance
f the method in the diagnosis of the disease.6 In this paper,
e present a didactic, non-systematic review on the subject,
ighlighting the indications of NFC and clinical implications
f its main ﬁndings in the daily practice of the rheumatologist.
ndications  of  capillaroscopy  in  rheumatology
atients with RP represent a common diagnostic challenge
n the practice of Rheumatology, with a broad differential
iagnosis. Moreover, they constitute the main indication
or NFC. RP is an exaggerated physiological response of the
icrocirculation of the extremities, face to precipitating fac-
ors such as exposure to cold or emotional stress. Its classic
resentation includes three phases: (1) the ﬁrst is represented
y ischemia, when the ﬁngers assume a white color; (2)
hen, with the occurrence of blood stasis, the extremities
urn to a blue color (cyanosis); (3) and ﬁnally the red color
ppears, indicating the stage of reperfusion. RP may be pri-
ary, or secondary to a number of conditions and diseases.
rimary RP is a benign condition characterized by functional
hanges of blood vessels and/or their innervation, and by
eﬁnition does not progress to an irreversible tissue damage.
iagnostic criteria for primary RP were proposed in 1992 by
eRoy et al., and included the presence of a normal NFC.7
ore  recently, new criteria were proposed, including: (1) the
resence of a clinical diagnosis of biphasic RP; (2) a normal
FC; (3) a physical examination with no ﬁndings suggestive
f a secondary cause for RP (ulceration, gangrene, necrosis,
clerodactyly, calcinosis or skin thickening); (4) no history of
utoimmune rheumatic disease; and (5) negative or low-titer
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At the other extreme, in patients with RP secondary to SSc
spectrum diseases, RP attacks tend to be more  severe and
may be associated with complications such as ulceration, scar-
ring, gangrene and/or digital amputation. Various rheumatic
diseases may present with RP, including, in addition to
SSc, systemic lupus erythematosus (SLE), dermatomyosi-
tis/polymyositis (DM/PM), mixed connective tissue disease
(MCTD), rheumatoid arthritis, Sjögren’s syndrome, vasculi-
tides and antiphospholipid syndrome. However, RP assumes
greater importance in the scleroderma spectrum of diseases.
Notably, RP is often the ﬁrst manifestation of the disease
in about 75% of patients with SSc, besides being associ-
ated with signiﬁcant morbidity and increased therapeutic
difﬁculties.9–11
In this context, NFC plays a key role in the distinction
between primary and secondary RP, and can also aid in clin-
ical and evolutionary characterization of these subjects, as
well as reducing costs with an unnecessary workup.12–14 A
meta-analysis showed that 12.6% of patients initially identi-
ﬁed as suffering from primary RP develop a secondary cause
for this phenomenon.10 Another recent study showed that
approximately 20% of these patients progress to a deﬁnitive
or suspected diagnosis of secondary RP at a 10-year follow-
up.9 Different studies have been uniform in assigning to NFC
a crucial role in monitoring the transition from primary to
secondary RP.15–18 A meta-analysis by Spencer-Green et al.
showed a positive predictive value of 47% for the presence of
alterations in NFC, a value higher than the predictive value
for the presence of autoantibodies (30%).10 When presence of
speciﬁc autoantibodies in SSc were associated with abnormal
capillaroscopy ﬁndings, the positive predictive value for the
development of SSc reaches 79.5% in 15 years.18 The main
indications for NFC are summarized in Table 1.
Technical  aspects
Equipment
Didactically, we  can enumerate three possibilities for the visu-
alization of the terminal row of capillary loops (Fig. 1):
(1) Stereomicroscope: magniﬁcation capacity 10–50 times;
allows the realization of panoramic NFC. With the ste-in SSc
(f) Monitoring of treatment and disease activity in
dermatomyositis
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stereFig. 1 – Devices that can be used for nailfold capillaroscopy: 
today in national and international centers, due to its ease
of use and low cost.
(2) Ophthalmoscope and dermatoscope: provide images with
lower magniﬁcation and quality. These techniques can
be an alternative to the bedside exams, or as a form of
screening in medical ofﬁces that do not have a stereomi-
croscope or a videocapillaroscope20,21; and
(3) Videocapillaroscopy: consists of the combination of a
microscope with a larger magniﬁcation lens coupled
with a digital video camera. This technique provides a
signiﬁcantly higher increase (200–600-fold) compared to
the stereomicroscope; and, with the aid of speciﬁc soft-
wares, allows a precise measurement of capillaroscopic
parameters (capillary length, width and density).13,22 One
of the disadvantages of the technique is the loss of
panoramic view of the capillary loops; only one area
of the nailfold region may be examined at any given
time.
Recently, a study from our group, comparing videocapil-
laroscope versus stereomicroscope, showed similar diagnostic
performance and reproducibility of the two methods.22
How  to  perform  the  examination
Whichever method is used, initially the patient must remain
in an acclimatized room for 15–20 min  with its temperature
around 20–22 ◦C. For better visualization of the capillaries, a
drop of immersion oil is placed on the cuticle of the ﬁngers to
be evaluated. The periungual region of the ten or eight ﬁngers
(excluding the thumb) should be examined. In this region, the
distal row of capillary loops protrudes into the dermal papillae,
Fig. 2 – Images of capillaroscopy with a normal capillaroscopic p
micro-hemorrhages, dilated capillaries, megacapillaries and avaomicroscope (A); dermatoscope (B); videocapillaroscope (C).
allowing a longitudinal view of its three (afferent, efferent and
transition) segments, arranged in a direction parallel to the
skin surface.23
The following parameters are routinely evaluated: num-
ber of loops/mm, number of dilated capillaries (with ectasia
and/or megacapillaries), devascularization, the presence of
micro-hemorrhages, and meandering, tortuous or branched
capillaries. The presence of devascularization can be assessed
by the number of loops/mm or by a devascularization
score, graded 0–3, where 0 corresponds to the absence of
devascularization, and 3 to extensive areas of avascularity.
Capillaroscopic parameters may also be graded using the
method proposed by Cutolo et al., in which the capillary abnor-
malities are graded according to their intensity, as follows:
score 0 – no changes; score 1 – <33% of capillary changes; score
2 – 33–66% of capillary changes; score 3 – >66% of capillary
changes.24 By convention, an abnormal capillaroscopic ﬁnd-
ing is considered signiﬁcant if it is observed in at least two
ﬁngers of the individual.12,13,25
Capillaroscopic  patterns
Normal  capillaroscopic  pattern
In healthy individuals, the capillaries have homogeneous size,
shape and color, and are arranged transversely across the
cuticle (Fig. 2A). The capillary loops may present discreet mor-
phological variations, such as crossed or meandering loops
(with intertwining). The subpapilar venous plexus can be
seen in varying extent in approximately 60% of the popula-
tion, with greater visibility expected in children and in white
attern (A) and with SD pattern, in which presence of
scular areas can be observed (B).
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eople.5,19 The normal capillary density, obtained by counting
he number of loops in one millimeter, ranges from 7 to 12
apillaries, averaging 9 capillaries/mm; most researchers con-
ider as a parameter of normality in adults the presence of
9 loops/mm.22,25 A small number of capillary dilations (ecta-
ia) may also be observed, but the ﬁnding of megacapillaries
r areas of devascularization should be considered abnormal,
xcept in the latter case, if the devascularization is asso-
iated with traumatic microscars in the periungual region.
imilarly, small areas of micro-bleeding with focal distribu-
ion can be observed in healthy individuals, associated with
veryday microtrauma. During the exam, it is useful to con-
ider that there is great variation in the shape and size of the
apillary loops among healthy individuals, and even among
ngers of the same person. Therefore, in these cases a mis-
iagnosis of microangiopathy should be avoided. Thus, the
raining and development are essential factors in the forma-
ion of capillaroscopists.26
D  (scleroderma)  pattern
irst described by Maricq et al., the SD pattern corresponds
o a set of typical NFC changes characterized by the presence
f dilated capillaries (ectasia and/or megacapillaries), loss of
apillary loops, with consequent reduction in the number
f capillaries, micro-bleeding and neoangiogenesis (branched
apillaries) (Fig. 2B).4,27 The SD pattern is present in 83–98% of
ases of SSc, although it is also observed in MCTD, DM and in
verlap syndromes.13,28
Additionally, Cutolo et al. classiﬁed capillaroscopy changes
ssociated with SD pattern in three stages: recent, active and
ate.24 In the “recent” pattern, micro-hemorrhages, and ecta-
ia (including megacapillaries) predominate, with a relatively
reserved capillary distribution and with no signiﬁcant devas-
ularization. These ﬁndings are crucial for early diagnosis of
Sc. In the “active” pattern, an increase in the number of
iant capillaries (megacapillaries) and micro-hemorrhages are
bserved, in association with a moderate loss of capillaries
nd mild distortion of capillary architecture. The “late” pattern
s characterized by a severe loss of capillaries and by exten-
ive avascular areas, neoangiogenesis and disorganization of
apillary architecture. In this study, the late pattern changes
orrelated with the duration of RP and diagnosis of SSc.
onspeciﬁc  microangiopathy
onspeciﬁc changes characterized by the presence of elon-
ated or tortuous capillaries, discreet presence of dilated
apillaries and increased visibility of the subpapilar venous
lexus are described in a number of conditions. Their real sig-
iﬁcance must be interpreted within the clinical context of
ach patient.
apillaroscopy  in  autoimmune  rheumatic
iseasesystemic  sclerosis
s previously mentioned, approximately 90% of patients
ith SSc exhibit the SD pattern in NFC. A microangiopathy 5;5 5(3):264–271 267
typical of SSc is found in the early stages of the disease,
often only when RP is present. The correlation between
capillaroscopic ﬁndings and the duration of the disease is
controversial. Some authors describe a more  pronounced
presence of dilated capillaries and micro-hemorrhages in
the early years of disease, and a more  intense disorganiza-
tion and devascularization in later stages. However, it is not
uncommon to ﬁnd patients with many  years of illness and
little devascularization; on the other hand, patients with lit-
tle disease duration and intense degree of devascularization
and disorganization of the capillary architecture can also be
seen.2
SSc is a chronic disease associated with high morbid-
ity and mortality. In this sense, it has been increasingly
emphasized the need for an early diagnosis of the disease,
when there is as yet no evidence of ﬁbrosis of internal
organs and of irreversible damage.6,13,28 In this scenario, NFC
acquires its great practical importance. It is noteworthy that
the ACR (1980) classiﬁcation criteria for SSc, based mainly
on clinical manifestations of a well-established disease, did
not allow its early recognition. In this context, LeRoy and
Medsger proposed in 2001 criteria for the early diagnosis
of SSc, which include a combination of clinical (Raynaud’s
phenomenon), imaging (nailfold capillaroscopy with SD pat-
tern) and laboratory (presence of SSc-speciﬁc autoantibodies)
data.29
Recently, the Research Group on Scleroderma from EULAR
suggested preliminary criteria for the very early diagnosis of
SSc using the same three domains, with the addition of the
presence of swollen ﬁngers and a positive result for antinu-
clear factor.30
Corroborating the importance of NFC in the diagnosis of
SSc, ACR and EULAR proposed in 2013 new criteria for the clas-
siﬁcation of SSc.6 According to these new criteria, the patient
is classiﬁed as having SSc if he/she get a total of nine or more
points among those eight items listed in Table 2, with a sensi-
tivity of 91% and speciﬁcity of 92% in a cohort study, compared
to a sensitivity of 75% and speciﬁcity of 72% with the applica-
tion of the 1980 ACR criteria.
Systemic  lupus  erythematous
Capillaroscopy changes in SLE are less speciﬁc than in SSc,
being characterized by the presence of tortuous and mean-
dering capillaries, bizarre loops and a prominent subpapilar
plexus, leading some authors to postulate the presence of a
typical capillaroscopic pattern.31 The presence of alterations
in NFC is more  frequent in patients with SLE presenting RP.32
However, 50% of patients with SLE have normal NFC. SD pat-
tern is a less common ﬁnding and has been described in 2–9%
of patients.33,34 In these patients, there seems to be a correla-
tion between the presence of SD pattern, ﬁngertips vasculitis
and anti-U1-RNP antibodies.34,35
Recently, recommendations for the screening and detec-
tion of pulmonary arterial hypertension in patients with
autoimmune rheumatic diseases suggested that patients with
SLE with characteristics of SSc spectrum of diseases, for exam-
ple, the presence of NFC with SD pattern, should also perform
an annual screening for the diagnosis of pulmonary arterial
268  r e v b r a s r e u m a t o l . 2
Table 2 – Classiﬁcation criteria for SSc proposed by ACR
and EULAR (2013).6
Item Sub-item Valor




Skin thickening of the ﬁngers
(only consider the higher
score)
Sclerodactily of the




Fingertip lesions (only consider
the higher score)
Puffy ﬁngers 2
Raynaud’s phenomenon Digital ulcers 2











patients with SSc. Different studies have demonstrated anhypertension and/or
interstitial lung disease
hypertension, suggesting a major role of NFC in identifying
this subtype of patients.36
Dermatomyositis  and  polimyositis
The prevalence of DM/PM in RP ranges from 10 to 60%, but the
presence of complications such as digital necrosis is rare.37
The SD pattern is observed in about 20–60% of patients with
DM/PM, with more  frequent and pronounced ﬁndings in DM
than in PM;  it correlates with the presence of RP and inter-
stitial pulmonary involvement.38 The presence of branched
capillaries is more  common in DM,  but their presence is not
speciﬁc and can also be found less frequently in patients with
SSc. In studies with juvenile DM,  the SD pattern is most com-
mon, having a positive association with severity and clinical
and laboratory activity of the disease.39–41
Mixed  connective  tissue  disease
RP is one of the initial manifestations of the disease, occur-
ring in approximately 85% of patients with MCTD and is also
part of the main classiﬁcation criteria for this disease.42 SD
pattern is observed in 50–65% of cases. A correlation between
capillaroscopy ﬁndings and pulmonary involvement in MCTD
is also described.43
Undifferentiated  connective  tissue  disease  (UCTD)
The term UCTD is used when, in the presence of clinical
manifestations suggestive of systemic autoimmune disease,
a shortage of clinical and/or laboratory data does not allow
the characterization of a speciﬁc clinical entity. The follow-
up of this group of patients points to a clinical outcome for
SSc, SLE, rheumatoid arthritis or Sjögren’s syndrome in 30%
of cases. Nagy et al. found a prevalence of 13.8% for SD pat-
tern in 65 patients with UCTD and suggested that NFC be 0 1 5;5 5(3):264–271
performed in all cases of UCTD with the aim of identifying
patients at higher risk for progression to SSc or to its spectrum
diseases.33
Primary  Sjögren  syndrome  (SS)
In SS, the capillaroscopic ﬁndings differ, depending on the
presence or absence of RP, present in 13–30% of patients.44,45
In primary SS without RP, NFC is normal in more  than half
of patients; the other patients present nonspeciﬁc capillaro-
scopic ﬁndings, including the presence of tortuous, irregular
capillaries and of a more  evident subpapilar plexus. When
there is presence of RP, most patients also show nonspeciﬁc
capillaroscopic ﬁndings. The SD pattern was described in
two of 16 patients (12.5%) with SS in one study.46 In the
subgroup of patients with SS and with positivity for anticen-
tromere, the researchers found a prevalence of 80% of the
SD pattern, indicating a potential for subclinical overlap with
SSc.46
Rheumatoid  arthritis  (RA)
In patients with RA there is no description of a SD pattern.2
Some studies show the presence of changes of uncertain rel-
evance in a proportion of patients, such as the presence of
elongated capillaries.2
Antiphospholipid  syndrome  (APS)
Presence of microbleeding distributed symmetrically is
described in APS patients and in SLE patients with pres-
ence of IgG and IgM anticardiolipin antibodies, suggesting
a direct damage of vascular endothelium triggered by these
antibodies.47,48
Capillaroscopy  as  a  marker  of  severity  of  systemic  sclerosis
Despite some controversial results, capillaroscopy also
assumes an important role in evaluating the severity of the
disease, visceral involvement, and prognosis of patients with
SSc. In 1976, Maricq et al. previously had found a correlation
between morphological changes of NFC and the number of
organs involved by the disease.49 Over the years, most stud-
ies found a correlation with the degree of microangiopathy
evaluated by NFC and peripheral vascular, cutaneous and pul-
monary involvement.2,16,50 Recently, a study of two  cohorts
of Belgian and Italian patients found an association between
the severity of capillaroscopy patterns and risk of severe
clinical involvement. Nine systems and/or organs (periph-
eral vascular, general, skin, joints, muscles, gastrointestinal
tract, lung, heart and kidneys) were evaluated according to
Medsger severity scale. There was an association between
risk of serious visceral injury and early, active and late pat-
terns, and the risk was higher in patients presenting the late
pattern.51
Digital ulcers are common vascular complications inassociation between the score of capillary loss or more  severe
changes in NFC and increased risk for development of dig-
ital ulcers.52,53 A recent study proposed a capillaroscopic
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ndex (CSURI) to predict the emergence of new ulcers in SSc
atients.53 Taken together, these results suggest the NFC rou-
ine use in patients with SSc, aiming the identiﬁcation of
atients with increased risk for development of this compli-
ation.
Regarding pulmonary involvement, a study found a sig-
iﬁcantly lower capillary density in patients with pulmonary
rterial hypertension associated with SSc, compared with
atients without pulmonary hypertension.54 In another study,
redemeier et al. found a correlation between higher scores for
vascular areas and ground-glass opacities in 91 patients with
Sc.55
Finally, a study from our group demonstrated an asso-
iation between risk of death and higher scores for
evascularization (>1.5) in NFC in a group of 125 patients with
Sc.56
onclusions
apillaroscopy is an extremely useful and reliable method
or the differential diagnosis between primary and secondary
P. Additionally, the use of NFC may aggregate information
bout the disease severity and degree of visceralization in
atients with SSc. Currently, two methods are most used
or performing NFC: panoramic nailfold capillaroscopy, using
 stereomicroscope, and videocapillaroscopy, which uses
arger magniﬁcations and a computerized system of image
cquisition.3 Both have advantages and disadvantages; how-
ver, they are equivalent for the identiﬁcation of classical
bnormalities, allowing the recognition of three patterns: nor-
al  pattern, nonspeciﬁc microangyopathy and SD pattern.23
he inclusion of capillaroscopic abnormalities in the new
lassiﬁcation criteria of the ACR/EULAR for SSc gives a new
mpetus to the use and dissemination of capillaroscopy. The
ducation and training of rheumatologists qualiﬁed to per-
orm the capillaroscopy was an issue neglected for years, with
revalence of self-teaching. EULAR promotes regular courses
n capillaroscopy. In Brazil, the ﬁrst course of capillaroscopy in
utoimmune rheumatic diseases was conducted in 2011 by the
iscipline of Rheumatology of Universidade Federal de São Paulo.
issemination, training and improvement of the method must
emain in the specialty agenda.
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